Arginase I Deficiency
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Safety of Weekly Subcutaneous Pegzilarginase in Subjects With Arginase 1 Deficiency (NCT05676853) | Aeglea Biotherapeutics | 2023-04-04 |
| Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency (NCT03921541) | Immedica Pharma AB | 2019-05-01 |
| A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency (NCT03378531) | Aeglea Biotherapeutics | 2017-12-07 |
| A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency (NCT02488044) | Aeglea Biotherapeutics | 2016-06-01 |
Track Arginase I Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.